Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
about
Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesiaOxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients.Exogenous and endogenous opioid-induced pain hypersensitivity in different rat strains.Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.A genetic analysis of opioid-induced hyperalgesia in mice.Influence of clonidine and ketamine on m-RNA expression in a model of opioid-induced hyperalgesia in miceDextromethorphan attenuated the higher vulnerability to inflammatory thermal hyperalgesia caused by prenatal morphine exposure in rat offspring.Sensitization of enteric neurons to morphine by HIV-1 Tat protein.Opioid-induced hyperalgesia in community-dwelling adults with chronic painTolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats.Opioid-independent mechanisms supporting offset analgesia and temporal sharpening of nociceptive informationPronociceptive and Antinociceptive Effects of Buprenorphine in the Spinal Cord Dorsal Horn Cover a Dose Range of Four Orders of Magnitude.From migraine to chronic daily headache: the biological basis of headache transformation.Opioidergic and dopaminergic modulation of respiration.Pain and u-shaped dose responses: occurrence, mechanisms, and clinical implications.Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon.Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.Tolerance and addiction; the patient, the parent or the clinician?Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies.Opioid-induced hyperalgesia and burn pain.Lack of association between the C276T polymorphism of the neuronal nitric oxide synthase gene and migraine.Association between human mu-opioid receptor gene polymorphism, pain tolerance, and opioid addiction.Influence of intramuscular heat stimulation on modulation of nociception: complex role of central opioid receptors in descending facilitation and inhibition.Increased pain sensitivity in chronic pain subjects on opioid therapy: a cross-sectional study using quantitative sensory testing.Intestinal inflammation alters the susceptibility to pentylenetetrazole-induced seizure in mice.NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL/6J mice.Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.The dark side of opioids in pain management: basic science explains clinical observation.
P2860
Q24648394-F9DDC60A-CC98-4EBC-95B8-7D388CA94C04Q33793250-6C467CAF-153A-4684-9FAE-F609C7952A94Q34119496-1FAB684B-EEC8-478D-A1E3-3E8CB0E3D3A1Q34154391-75D892F8-5B7C-49FA-851B-D188357B53C6Q34485532-19D87602-2A99-4415-91F4-56860DA96A98Q34625018-57933CA7-BC44-47A1-A942-2D104EAF4DFAQ35041398-A9CFC791-FB6D-4122-8E6C-AA854FFE67CBQ35232054-EB30C473-390E-48FB-AC45-FCC0FB718330Q35236345-2AFE64D2-9625-4199-BDFD-038F97EC7FE8Q35607002-F0106957-0F60-4F4C-9338-31D233990780Q35765718-B8F18152-79FF-4339-B62B-4E333BC7275EQ35981314-5B20CC97-8A28-4030-ACA3-0CC78F71293CQ36064141-15331DF4-4E6E-4BF8-85C0-634C892040BBQ36947165-4035030D-09BB-409C-B3C1-C4AB9E2D091CQ37097637-6160209A-F1E0-4908-B0B9-57F21FF834D8Q37246019-725431A7-4E83-4F30-900B-A680C4DCF772Q37420079-EFCEB5E7-07E3-47F1-9D8B-84BFAA3BDB0EQ37736976-42F85991-5CCB-4C21-BC61-D5FEAC15EEFBQ37825586-9F7A62EC-69F4-490F-A00D-80CA2BDF97A6Q37858847-6E6A4603-C5C7-485C-9205-285BF906ADE4Q38059162-24429CF8-1AF4-46B9-BB13-0138D1E90383Q44175703-F7AD8755-B3C1-4B31-A246-1CC71C10415EQ44342438-D3143B94-8DDD-4C80-8052-FFA14A73A709Q44345973-13A7050C-6DB6-4965-A681-0B68D044AC92Q44348089-5B2C34F7-DFAB-43A3-B83A-8A588741A465Q44746122-19B21EB6-64A2-4CCE-AD8C-C6DF60EDDB90Q46854772-5ED3B62B-3EC0-46BF-A109-A758F1251336Q48605819-CCEF39EB-B4FB-4F7B-90E9-C8720B5A00B9Q49384858-0EDB329C-C3AD-4277-A21E-6A760E67265A
P2860
Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
@en
Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
@nl
type
label
Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
@en
Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
@nl
prefLabel
Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
@en
Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
@nl
P2093
P1433
P1476
Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
@en
P2093
P356
10.1016/S0006-8993(99)01998-8
P407
P577
1999-11-01T00:00:00Z